Camino de Santiago Trek 2026
Could you take on an adventure of a lifetime for Retina UK and take part in the Camino de Santiago, across Spain in September 2026?
Search results
Could you take on an adventure of a lifetime for Retina UK and take part in the Camino de Santiago, across Spain in September 2026?
Could you take on an adventure of a lifetime for Retina UK and take part in the Great Wall of China Trek in November 2026?
Could you take on an adventure of a lifetime for Retina UK and take part in the Sahara Desert Trek in November 2026?
During our 50th anniversary year, take to the skies with an epic spring skydive for Retina UK!
Welcome to the winter edition of Look Forward. It’s packed full of news from our Conferences, the latest research news and an interview with Hassina Zeriri, one of our funded PhD students.
We have also included details of lots of ways you can get involved with Retina UK over the coming months, along with some suggested festive fundraising for the Christmas period.
Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.
The BBC covered a story on Monday 24 May about optogenetics partially restoring the sight of a man living with retinitis pigmentosa in France.
The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).
Stem cells are a special type of cell, which under the right conditions can be encouraged to grow into any other type of cell in the body, including retinal cells (rods, cones and retinal pigment epithelial cells).
As people living with sight loss we are constantly looking for solutions to make our lives easier without too much effort or cost writes Jonathan Abro.